127 related articles for article (PubMed ID: 25361959)
21. Thrombospondin-1 induces matrix metalloproteinase-2 activation in vascular smooth muscle cells.
Lee T; Esemuede N; Sumpio BE; Gahtan V
J Vasc Surg; 2003 Jul; 38(1):147-54. PubMed ID: 12844104
[TBL] [Abstract][Full Text] [Related]
22. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
Wu D; Cederbaum A
Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
24. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
[TBL] [Abstract][Full Text] [Related]
25. Thrombospondin-1-induced vascular smooth muscle cell migration and proliferation are functionally dependent on microRNA-21.
Stein JJ; Iwuchukwu C; Maier KG; Gahtan V
Surgery; 2014 Feb; 155(2):228-33. PubMed ID: 24314882
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic switching prevention and proliferation/migration inhibition of vascular smooth muscle cells by the ruthenium nitrosyl complex trans-[Ru(NO)Cl(cyclam](PF
de Oliveira MG; Doro FG; Tfouni E; Krieger MH
J Pharm Pharmacol; 2017 Sep; 69(9):1155-1165. PubMed ID: 28590566
[TBL] [Abstract][Full Text] [Related]
27. Thrombospondin mediates migration and potentiates platelet-derived growth factor-dependent migration of calf pulmonary artery smooth muscle cells.
Yabkowitz R; Mansfield PJ; Ryan US; Suchard SJ
J Cell Physiol; 1993 Oct; 157(1):24-32. PubMed ID: 8408239
[TBL] [Abstract][Full Text] [Related]
28. Statin-induced vascular smooth muscle cell apoptosis: a possible role in the prevention of restenosis?
Erl W
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):135-44. PubMed ID: 15853755
[TBL] [Abstract][Full Text] [Related]
29. Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells.
Muzaffar S; Shukla N; Bond M; Newby AC; Angelini GD; Sparatore A; Del Soldato P; Jeremy JY
J Vasc Res; 2008; 45(6):521-8. PubMed ID: 18463417
[TBL] [Abstract][Full Text] [Related]
30. High glucose oxidizes SERCA cysteine-674 and prevents inhibition by nitric oxide of smooth muscle cell migration.
Tong X; Ying J; Pimentel DR; Trucillo M; Adachi T; Cohen RA
J Mol Cell Cardiol; 2008 Feb; 44(2):361-9. PubMed ID: 18164028
[TBL] [Abstract][Full Text] [Related]
31. Vascular smooth muscle cell migration induced by domains of thrombospondin-1 is differentially regulated.
Seymour KA; Sadowitz B; Stein JJ; Lawler J; Maier KG; Gahtan V
Am J Surg; 2011 Nov; 202(5):553-7. PubMed ID: 21906719
[TBL] [Abstract][Full Text] [Related]
32. A redox-based mechanism for nitric oxide-induced inhibition of DNA synthesis in human vascular smooth muscle cells.
Bundy RE; Marczin N; Chester AH; Yacoub M
Br J Pharmacol; 2000 Apr; 129(7):1513-21. PubMed ID: 10742309
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
Kowaluk EA; Fung HL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1256-64. PubMed ID: 2175799
[TBL] [Abstract][Full Text] [Related]
34. The effects of HMG-CoA reductase inhibitor on vascular progenitor cells.
Kusuyama T; Omura T; Nishiya D; Enomoto S; Matsumoto R; Murata T; Takeuchi K; Yoshikawa J; Yoshiyama M
J Pharmacol Sci; 2006 Aug; 101(4):344-9. PubMed ID: 16891763
[TBL] [Abstract][Full Text] [Related]
35. Effects of statin treatment and withdrawal on angiotensin II-induced phosphorylation of p38 MAPK and ERK1/2 in cultured vascular smooth muscle cells.
Tristano AG; Castejon AM; Castro A; Cubeddu LX
Biochem Biophys Res Commun; 2007 Feb; 353(1):11-7. PubMed ID: 17161379
[TBL] [Abstract][Full Text] [Related]
36. Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells.
Ali OF; Growcott EJ; Butrous GS; Wharton J
Respir Res; 2011 Oct; 12(1):137. PubMed ID: 21999923
[TBL] [Abstract][Full Text] [Related]
37. Fluvastatin inhibits intimal hyperplasia in wild-type but not Thbs1-null mice.
Desai P; Helkin A; Odugbesi A; Stein J; Bruch D; Lawler J; Maier KG; Gahtan V
J Surg Res; 2017 Apr; 210():1-7. PubMed ID: 28457315
[TBL] [Abstract][Full Text] [Related]
38. Statins restore ischemic limb blood flow in diabetic microangiopathy via eNOS/NO upregulation but not via PDGF-BB expression.
Fujii T; Onimaru M; Yonemitsu Y; Kuwano H; Sueishi K
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2785-91. PubMed ID: 18441206
[TBL] [Abstract][Full Text] [Related]
39. Lipophilic statins induce apoptosis of human vascular smooth muscle cells.
Guijarro C; Blanco-Colio LM; Massy ZA; O'Donnell MP; Kasiske BL; Keane WF; Egido J
Kidney Int Suppl; 1999 Jul; 71():S88-91. PubMed ID: 10412746
[TBL] [Abstract][Full Text] [Related]
40. Thrombospondin-1-induced vascular smooth muscle cell migration is dependent on the hyaluronic acid receptor CD44.
Maier KG; Sadowitz B; Cullen S; Han X; Gahtan V
Am J Surg; 2009 Nov; 198(5):664-9. PubMed ID: 19887196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
